BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19589890)

  • 1. Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts.
    Garcia-Gonzalez E; Selvi E; Balistreri E; Lorenzini S; Maggio R; Natale MR; Capecchi PL; Lazzerini PE; Bardelli M; Laghi-Pasini F; Galeazzi M
    Rheumatology (Oxford); 2009 Sep; 48(9):1050-6. PubMed ID: 19589890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model.
    Balistreri E; Garcia-Gonzalez E; Selvi E; Akhmetshina A; Palumbo K; Lorenzini S; Maggio R; Lucattelli M; Galeazzi M; Distler JW
    Ann Rheum Dis; 2011 Apr; 70(4):695-9. PubMed ID: 21177293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes.
    Selvi E; Lorenzini S; Garcia-Gonzalez E; Maggio R; Lazzerini PE; Capecchi PL; Balistreri E; Spreafico A; Niccolini S; Pompella G; Natale MR; Guideri F; Laghi Pasini F; Galeazzi M; Marcolongo R
    Clin Exp Rheumatol; 2008; 26(4):574-81. PubMed ID: 18799087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system.
    Lazzerini PE; Natale M; Gianchecchi E; Capecchi PL; Montilli C; Zimbone S; Castrichini M; Balistreri E; Ricci G; Selvi E; Garcia-Gonzalez E; Galeazzi M; Laghi-Pasini F
    J Mol Med (Berl); 2012 Mar; 90(3):331-42. PubMed ID: 22033526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.
    García-Arencibia M; González S; de Lago E; Ramos JA; Mechoulam R; Fernández-Ruiz J
    Brain Res; 2007 Feb; 1134(1):162-70. PubMed ID: 17196181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.
    Scholl A; Ivanov I; Hinz B
    Oncotarget; 2016 Sep; 7(38):61438-61457. PubMed ID: 27556861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of bcl-xL gene expression.
    Pozzoli G; Tringali G; Vairano M; D'Amico M; Navarra P; Martire M
    J Neurosci Res; 2006 May; 83(6):1058-65. PubMed ID: 16609959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK.
    Feng YJ; Li YY; Lin XH; Li K; Cao MH
    World J Gastroenterol; 2016 Nov; 22(43):9515-9524. PubMed ID: 27920472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
    Rahn EJ; Makriyannis A; Hohmann AG
    Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
    Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for cannabinoid therapies in viral encephalitis.
    Solbrig MV; Fan Y; Hazelton P
    Brain Res; 2013 Nov; 1537():273-82. PubMed ID: 24021420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
    Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
    J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells.
    Echigo R; Sugimoto N; Yachie A; Ohno-Shosaku T
    Oncol Rep; 2012 Oct; 28(4):1176-80. PubMed ID: 22842590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma.
    Gustafsson K; Christensson B; Sander B; Flygare J
    Mol Pharmacol; 2006 Nov; 70(5):1612-20. PubMed ID: 16936228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis.
    Petrella C; Agostini S; Alema' GS; Casolini P; Carpino F; Giuli C; Improta G; Linari G; Petrozza V; Broccardo M
    Neurogastroenterol Motil; 2010 Nov; 22(11):1248-56, e323. PubMed ID: 20659297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1.
    Kong Y; Wang W; Zhang C; Wu Y; Liu Y; Zhou X
    Mol Med Rep; 2016 Jun; 13(6):4569-76. PubMed ID: 27082728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists.
    Ribeiro R; Wen J; Li S; Zhang Y
    Prostaglandins Other Lipid Mediat; 2013 Jan; 100-101():1-14. PubMed ID: 23219970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.
    de Lago E; Moreno-Martet M; Cabranes A; Ramos JA; Fernández-Ruiz J
    Neuropharmacology; 2012 Jun; 62(7):2299-308. PubMed ID: 22342378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis Overexpress Activated ADAM12 and Are Involved in Myofibroblast Transdifferentiation and Development of Fibrosis.
    Cipriani P; Di Benedetto P; Ruscitti P; Liakouli V; Berardicurti O; Carubbi F; Ciccia F; Guggino G; Zazzeroni F; Alesse E; Triolo G; Giacomelli R
    J Rheumatol; 2016 Jul; 43(7):1340-9. PubMed ID: 27252423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.